MRNA

Moderna

$34.30

+0.44 (+1.3%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 11.01.2026
$36.60
(+6.71%)
Strong Buy: 2
Buy: 3
Hold: 16
Sell: 1
Strong Sell: 2
Description:
Moderna, Inc. is a leading biotechnology company headquartered in Cambridge, Massachusetts, renowned for revolutionizing vaccine development through its proprietary messenger RNA (mRNA) technology. Gaining international acclaim for its pivotal role in producing one of the first effective COVID-19 vaccines, the company is actively broadening its research portfolio to encompass a diverse range of diseases, including cancer, rare disorders, cardiovascular diseases, and autoimmune conditions. With a robust pipeline and a strong commitment to scientific innovation, Moderna is positioned to transform healthcare by addressing critical unmet medical needs and enhancing patient outcomes worldwide.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
325 BINNEY STREET, CAMBRIDGE, MA, UNITED STATES, 02142
Fiscal year end:
December
Market capitalization:
$13.4 Billion
EBITDA:
-$3.26 Billion
PERatio:
0.0
EPS:
-8.06
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.174

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 7 years:
+59%
How much will you get:
$1,585
Prices dates:
07-12-2018: $18.60 and 31-12-2025: $29.49